Project Grant K08AI182477
Award Date
12/4/24
Completion Date
11/30/29
Dollars Obligated
$151K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $286,791 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the development and application of pediatric-specific blood transcriptional modules (PTBMs) through public data mining. The goal is to construct robust and widely applicable PTBMs that capture the heterogeneous physiological states of children aged 0-12 years across diverse geographical settings. This work aims to address...
This $1,297,775 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will fund a longitudinal study conducted by National Jewish Health to investigate the role of early-life skin dysfunction in the development of the "allergic march" - the progression from atopic dermatitis to food allergies and asthma in children.
The study will utilize skin tape stripping and RNA sequencing methods to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $266,615 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Rochester to train a diverse pool of medicine, pediatric, and dermatology residents as the next generation of physician-scientists. The primary goals of the "ROC STARR: Health and Immune Function Across the Lifespan" project are to:
Provide high-quality, rigorous training in translational, clinical,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to elucidate the pathways that lead to the differentiation of TFH13 cells, a novel T cell subset that drives the production of high-affinity, pathogenic IgE antibodies in allergic disease. The $586,250 award to the University of Massachusetts Medical School will support research to 1) determine the role of non-conventional antigen presenting...
This federal Project Grant award of $2,339,268 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to investigate the role of neuro-immune pathways in food allergies. The award period is from May 14, 2024 to April 30, 2029.
The key products and services delivered under this grant include:
Genetic engineering services to develop transgenic, gene knockout, and gene knockin mouse models to study food allergies (Sub-award...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $189,756 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Pittsburgh. The grant supports a 5-year research project titled "Altered CD4+ T Cell Responses and Resultant Asthma Following Neonatal Human Metapneumovirus Infection." The objective is to mechanistically evaluate how neonatal CD4+ T cell responses to human metapneumovirus (HMPV) infection...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $152,475 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Childrens Hospital Medical Center in Cincinnati, Ohio. The grant aims to develop an automated tool to simplify the transformation of laboratory test data from clinical trials into the required format for submission to the NIAID-funded Immunology Database and Analysis Portal (IMMPORT). This tool will facilitate the...
This Project Grant award, valued at $194,911, was provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Yale University. The award aims to optimize equitable peanut allergy prevention among high-risk infants through a multi-phase research study.
The key products and services to be delivered under this award include:
Exploring multi-level sociodemographic determinants of peanut introduction in high-risk infants (Aim...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $868,776 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital Corporation (Boston Children's Hospital). The grant is to fund a 5-year project from February 2025 to January 2030 to characterize a novel post-transcriptional regulator in the opportunistic pathogen Pseudomonas aeruginosa. Key objectives include identifying the direct regulatory targets of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $658,426 to The Children's Hospital of Philadelphia (CHOP) over a 5-year period from December 2024 to November 2029. The funding supports research to investigate the role of the CD39/adenosine axis in impairing CD8 T cell function in patients with STAT3 gain-of-function, a rare inflammatory disease. Specifically, the project aims...